Literature DB >> 10680887

Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases.

H Tsuda1, T Takarabe, F Hasegawa, T Fukutomi, S Hirohashi.   

Abstract

High-grade invasive ductal carcinomas (IDCs) of the breast with large, central acellular zones on their cut surfaces are usually associated with the myoepithelial immunophenotype of carcinoma cells, which includes the expression of S-100 protein, alpha-smooth muscle actin, and keratin 14. To clarify the clinical significance of these features of IDCs, the authors compared the incidence of the myoepithelial immunophenotype immunohistochemically, patient prognosis, and metastatic sites of the tumor between 20 high-grade IDCs with large, central acellular zones and 40 control high-grade IDCs without these zones. The myoepithelial immunophenotype was detected in 16 IDCs (80%) with large, central acellular zones but in only seven IDCs (18%) without. The risk ratio of metastasis, especially in the brain and lung, and death from cancer were significantly higher (p = 0.0096 and p = 0.030) for the 20 IDCs with large, central acellular zones than for those without by Cox's univariate analysis. Using Cox's multivariate analysis, large, central acellular zones in IDCs were an indicator of high risk of brain and lung metastases and of death by cancer independent of nodal status and tumor size. Examination of large, central acellular zones and myoepithelial immunophenotype in high-grade IDCs appears helpful in predicting patient prognosis and preferential metastatic sites of the tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10680887     DOI: 10.1097/00000478-200002000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  43 in total

1.  Collagen gel contraction serves to rapidly distinguish epithelial- and mesenchymal-derived cells irrespective of alpha-smooth muscle actin expression.

Authors:  Helga Lind Nielsen; Thorarinn Gudjonsson; René Villadsen; Lone Rønnov-Jessen; Ole William Petersen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jul-Aug       Impact factor: 2.416

2.  Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer.

Authors:  Daniel I Golden; Jafi A Lipson; Melinda L Telli; James M Ford; Daniel L Rubin
Journal:  J Am Med Inform Assoc       Date:  2013-06-19       Impact factor: 4.497

Review 3.  Myoepithelial cells: pathology, cell separation and markers of myoepithelial differentiation.

Authors:  Catherine Clarke; Jennifer Sandle; Sunil R Lakhani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-07       Impact factor: 2.673

4.  Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway.

Authors:  Lynn S Adams; Sheryl Phung; Natalie Yee; Navindra P Seeram; Liya Li; Shiuan Chen
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

5.  Immunohistochemical study of metaplastic carcinoma and central acellular carcinoma of the breast: central acellular carcinoma is related to metaplastic carcinoma.

Authors:  Rin Yamaguchi; Maki Tanaka; Keiko Kondo; Toshiro Yokoyama; Ichiro Maeda; Shin-Ichi Tsuchiya; Miki Yamaguchi; Ryuji Takahashi; Yutaka Ogata; Hideyuki Abe; Jun Akiba; Osamu Nakashima; Masayoshi Kage; Hirohisa Yano
Journal:  Med Mol Morphol       Date:  2012-03-20       Impact factor: 2.309

6.  "High-grade" central acellular carcinoma and matrix-producing carcinoma of the breast: correlation between ultrasonographic findings and pathological features.

Authors:  Rin Yamaguchi; Maki Tanaka; Yasuko Mizushima; Yoshitake Hirai; Miki Yamaguchi; Hiroshi Terasaki; Toshiro Yokoyama; Shin-ichi Tsuchiya; Osamu Nakashima; Hirohisa Yano
Journal:  Med Mol Morphol       Date:  2011-09-16       Impact factor: 2.309

Review 7.  Salivary gland-like tumours of the breast: surgical and molecular pathology.

Authors:  M Pia-Foschini; J S Reis-Filho; V Eusebi; S R Lakhani
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

8.  Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis.

Authors:  Mohammed S Fayaz; Mustafa S El-Sherify; Amany El-Basmy; Sadeq A Zlouf; Nashwa Nazmy; Thomas George; Susan Samir; Gerges Attia; Heba Eissa
Journal:  Rep Pract Oncol Radiother       Date:  2013-09-26

9.  Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

Authors:  Eugenio Maiorano; Meredith M Regan; Giuseppe Viale; Mauro G Mastropasqua; Marco Colleoni; Monica Castiglione-Gertsch; Karen N Price; Richard D Gelber; Aron Goldhirsch; Alan S Coates
Journal:  Breast Cancer Res Treat       Date:  2009-03-12       Impact factor: 4.872

Review 10.  Demystifying basal-like breast carcinomas.

Authors:  L Da Silva; C Clarke; S R Lakhani
Journal:  J Clin Pathol       Date:  2007-05-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.